HomeProvider StoriesUsing actionable information in treatment decisions Using actionable information in treatment decisions October 7, 2020 Jay Tillman, Psychiatrist, MDConnecticut My treatment philosophy for depression and other mental health conditions is that optimal mental health is achieved using the least medication at the lowest dose possible. I have 20 years of experience in psychiatry. I’ve worked with patients in nursing homes, skilled nursing home facilities for the developmentally disabled, and in general psychiatry in an outpatient setting. In my career, I have seen many treatment-resistant depression patients. Working with this population has been a privilege through which I have learned that there are always alternatives. A lot of my patients have seen multiple providers, are taking multiple medications, and have multiple medical diagnoses. It’s not uncommon for me to see a patient who is taking six or more different psychotropic medications along with 20 different medications for other conditions. In these cases, I know I must be methodical and make these changes slowly, reducing the number of variables to ensure that I understand what changes are most effective for the patient. Pharmacogenomic Testing When I first learned of pharmacogenomic testing – I’ll admit, I was very skeptical. I truly didn’t have a full understanding as to how it could be used. In talking with others in my profession, the biggest misunderstanding is that it can choose the medication that’s going to work the best for the patient. That’s simply not true. But it is very helpful. Pharmacogenomic tests like the GeneSight test give useful information that aids in making treatment decisions. It doesn’t remove the clinician’s role in treatment decisions – it provides personal information about a patient’s genetic code for more insightful decisions. Once I understood the information presented on the GeneSight report, it was incredible. Importantly, as a clinician, you still have your decision tree. The GeneSight test results augment your treatment decision tree. Helping End Trial and Error Medication failure is always a bad feeling as a provider, of course. When I see a patient’s intake form and find a long list of medications that they have tried and failed, it’s a red flag. So, if a patient has tried six medications and failed, I can try another, but how effective is the seventh medication trial going to be? In my experience, the more medication trials someone has had, the less effective the next medication is going to be. In these cases, I tell my patients that I want to give them the GeneSight test. Most patients are shocked that a test like this actually exists. For example, I had a patient who was taking six different psychotropic medications – and two of the medications were at a super high dosage. Yet, he was still symptomatic. Before I made a change, I asked if he would take the test. He agreed – and expressed his surprise that his previous psychiatrist had never shared that this test existed. His GeneSight test results showed that the two medications he was taking at super high dosages were in his significant gene-drug interaction category and were expected to be metabolized at a significantly different rate than normal. I recommend the GeneSight test to my colleagues. In fact, I’m always shocked if I talk to a treater who is not interested in the test. Psychiatry can be vague. Symptoms can change and side effects can be hard to determine. I tell them that using a data-driven approach with actionable information in treatment decisions was an eye opener and has proven to be useful in so many ways. Patient Antidepressant Fatigue in Seniors: A Caregiver’s Guide to Reducing Daytime Sleepiness Without Losing Symptom Control You’re spending time with the older adult in your care who also happens to have clinical depression. You’re keeping tabs on how well they’re doing and wheth... Read more Patient Empowering Senior Patient Care with Pharmacogenomics: Insights from the GeneSight Engage Webinar The most recent GeneSight Engage webinar explored how pharmacogenomic testing, particularly the GeneSight® test, is transforming the landscape of mental health ... Read more Patient BIPOC (formerly Minority) Mental Health Month: Breaking Stigma, Building Trust Despite many efforts to stem it, stigma around mental health still exists, particularly in BIPOC (Black, Indigenous, and People of Color) communities. July mark... Read more Patient Long-Term Effects of Antidepressants: What Research Shows Anyone who’s ever taken antidepressants for an extended period of time has probably wondered whether they’ll experience long-term effects: After years ... Read more Patient Have a Mindful Summer: Take a Breather with These Simple Exercises Summer is a great time to kick back and relax—if you can find the time. Managing the hustle and bustle of kids off school, planning for fun summer activities an... Read more Patient Barriers at Every Turn: How Systemic and Social Factors Block Men from Mental Health Care Taking the important step of seeking care for mental health isn’t always an easy decision. Uncertainty about the need for care, social stigmas associated wi... Read more Healthcare Provider Overcoming Side Effect Concerns: Leveraging Pharmacogenomic Insights to Inform Depression and Anxiety Medication Selection Whitnee Brown, a lifelong resident now practicing in Birmingham, Alabama has nearly an entire alphabet following her name, abbreviations for degrees and certifi... Read more Patient Concerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety Lisa Roberts has raised a family, reached an impressively high level in her career, and was an anchor for her mother and other family members. When, within ... Read more Patient Common Antidepressant Side Effects Taking an antidepressant can be an effective way to help treat a mental health condition like depression or anxiety. However, these medications can also cre... Read more Patient MTHFR Mutations: Clinical Implications and Management Strategies MTHFR mutations—changes in the methylenetetrahydrofolate reductase (MTHFR) gene—have gained increased attention in the medical community due to their potent... Read more Learn more Learn more about GeneSight How to talk to your provider View our clinical studies
Patient Antidepressant Fatigue in Seniors: A Caregiver’s Guide to Reducing Daytime Sleepiness Without Losing Symptom Control You’re spending time with the older adult in your care who also happens to have clinical depression. You’re keeping tabs on how well they’re doing and wheth... Read more
Patient Empowering Senior Patient Care with Pharmacogenomics: Insights from the GeneSight Engage Webinar The most recent GeneSight Engage webinar explored how pharmacogenomic testing, particularly the GeneSight® test, is transforming the landscape of mental health ... Read more
Patient BIPOC (formerly Minority) Mental Health Month: Breaking Stigma, Building Trust Despite many efforts to stem it, stigma around mental health still exists, particularly in BIPOC (Black, Indigenous, and People of Color) communities. July mark... Read more
Patient Long-Term Effects of Antidepressants: What Research Shows Anyone who’s ever taken antidepressants for an extended period of time has probably wondered whether they’ll experience long-term effects: After years ... Read more
Patient Have a Mindful Summer: Take a Breather with These Simple Exercises Summer is a great time to kick back and relax—if you can find the time. Managing the hustle and bustle of kids off school, planning for fun summer activities an... Read more
Patient Barriers at Every Turn: How Systemic and Social Factors Block Men from Mental Health Care Taking the important step of seeking care for mental health isn’t always an easy decision. Uncertainty about the need for care, social stigmas associated wi... Read more
Healthcare Provider Overcoming Side Effect Concerns: Leveraging Pharmacogenomic Insights to Inform Depression and Anxiety Medication Selection Whitnee Brown, a lifelong resident now practicing in Birmingham, Alabama has nearly an entire alphabet following her name, abbreviations for degrees and certifi... Read more
Patient Concerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety Lisa Roberts has raised a family, reached an impressively high level in her career, and was an anchor for her mother and other family members. When, within ... Read more
Patient Common Antidepressant Side Effects Taking an antidepressant can be an effective way to help treat a mental health condition like depression or anxiety. However, these medications can also cre... Read more
Patient MTHFR Mutations: Clinical Implications and Management Strategies MTHFR mutations—changes in the methylenetetrahydrofolate reductase (MTHFR) gene—have gained increased attention in the medical community due to their potent... Read more